The placebo capsules
Sponsors
Beijing Continent Pharmaceutical Co, Ltd.
Conditions
Liver Fibrosis
Phase 3
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
CompletedNCT05115942
Start: 2021-12-30End: 2024-10-22Updated: 2024-12-20
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
RecruitingNCT05905172
Start: 2023-08-12End: 2028-10-20Target: 248Updated: 2025-06-04